← Back to Clinical Trials
Recruiting NCT07327554

NCT07327554 Assessment of the Evolution of Lumbar Spine Movement Fluidity Using Xsens Inertial Sensors in Subjects With Chronic Low Back Pain Before and After Rehabilitation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07327554
Status Recruiting
Phase
Sponsor University Hospital, Montpellier
Condition Low Back Pain
Study Type INTERVENTIONAL
Enrollment 25 participants
Start Date 2026-02-23
Primary Completion 2027-04

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
X-sens sensor

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 25 participants in total. It began in 2026-02-23 with a primary completion date of 2027-04.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Low back pain, defined as pain located between the thoracolumbar junction and the lower gluteal fold, becomes chronic in 8% of patients. As the leading cause of disability worldwide, it has major individual and medico-economic consequences. Three-dimensional biomechanical analysis allows exploration of movement alterations related to low back pain. Although several parameters have already been studied (maximum joint range of motion (ROM), lumbopelvic rhythm, movement variability, gait), no consistent kinematic profile has emerged. Movement fluidity, assessed by the presence of jerks (brief movement disturbances), remains under-described despite its relevance in evaluating movement quality. Invistigators hypothesize that lumbar spine movement fluidity during flexion improves after a rehabilitation program and correlates with clinical response. This project stands out by exploring a rarely studied parameter (movement fluidity) and integrating it as a potential indicator for rehabilitation monitoring.

Eligibility Criteria

Inclusion Criteria: * Age between 18 and 65 years inclusive * BMI between 18-30 kg/m² * Chronic low back pain lasting more than three months * Rehabilitation care in the Physical Medicine and Rehabilitation Department of Montpellier University Hospital Exclusion Criteria: * Sciatica episode within the last three months * Traumatic, tumoral, or infectious cause of low back pain * History of spinal, pelvic, or hip fracture * Inflammatory rheumatism * Lumbar arthrodesis * Severe scoliosis * Subject with a legal protection measure (guardianship, curatorship) * Subject under legal protection * Subject not affiliated to a social security system or not benefiting from such a system * Absence of informed written consent * Pregnant or breastfeeding women

Contact & Investigator

Central Contact

Isabel TAVARES, MD

✉ i-tavaresfigueiredo@chu-montpellier.fr

📞 0467338717

Principal Investigator

Isabel TAVARES, MD

PRINCIPAL INVESTIGATOR

University Hospital, Montpellier

Frequently Asked Questions

Who can join the NCT07327554 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Low Back Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07327554 currently recruiting?

Yes, NCT07327554 is actively recruiting participants. Contact the research team at i-tavaresfigueiredo@chu-montpellier.fr for enrollment information.

Where is the NCT07327554 trial being conducted?

This trial is being conducted at Montpellier, France.

Who is sponsoring the NCT07327554 clinical trial?

NCT07327554 is sponsored by University Hospital, Montpellier. The principal investigator is Isabel TAVARES, MD at University Hospital, Montpellier. The trial plans to enroll 25 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology